d-MAPPS Ophthalmic Solution

· Regenerative Ocular Immunobiologics LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for d-MAPPS Ophthalmic Solution, covering 2025-10-10 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Study of d-MAPPS™ Ophthalmic Solution, Safety, Tolerability, and Efficacy in the Treatment of Chronic Ocular Graft-Versus-Host Disease (oGVHD) [Phase 1, Phase 2]

See pricing